Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Portola Pharma
3159
Portola Pharma
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Portola (Nasdaq: PTLA) is a biopharma co. focused on developing life-saving therapeutics in thrombosis and hematology. Twitter policy on our site
Suggest edits
Type
B2c
Founded
2003
Raised
$149.1M
Follow us
Also headquartered in Quito
EL MERCIO.
MANDACOB S.A. Factoring Ecuador
Kriptos
Unified Color
ADCstudio
AreaNaranja
YaEsta.com
Krugerlabs
Analytica Investments
Couchy.com
Companies in the same industry
Ventus Therapeutics
Vico Therapeutics
AstraZeneca
SutroVax
Bioquark Inc.
Arrivo BioVentures LLC
3D Bio Holdings
Egalet Corporation
C4X Discovery Ltd
Advicenne Pharma SA
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Acquired by
05 May 2020
Alexion Pharmaceuticals, Inc.
$1,400,000,000
Latest funding
$89,000,000
Venture capital (Series D) - 2011
Temasek Holdings
Eastern Capital
$60,100,000
Venture capital (Series C) - 2009
Adage Capital Management
Advanced Technology Ventures
D.E. Shaw & Co.
+15
Location
Quito
,
United States
Headquarters
Explore Quito
MedCity News
Alexion plunks down $1.4B to acquire Portola Pharmaceuticals
